malities in repolarization and its rate dependence are known to be related to increased proarrhythmic risk. A number of repolarizationrelated electrophysiological properties are commonly used as preclinical biomarkers of arrhythmic risk. However, the variability and complexity of repolarization mechanisms make the use of cellular biomarkers to predict arrhythmic risk preclinically challenging. Our goal is to investigate the role of ionic current properties and their variability in modulating cellular biomarkers of arrhythmic risk to improve risk stratification and identification in humans. A systematic investigation into the sensitivity of the main preclinical biomarkers of arrhythmic risk to changes in ionic current conductances and kinetics was performed using computer simulations. Four stimulation protocols were applied to the ten Tusscher and Panfilov human ventricular model to quantify the impact of Ϯ15 and Ϯ30% variations in key model parameters on action potential (AP) properties, Ca 2ϩ and Na ϩ dynamics, and their rate dependence. Simulations show that, in humans, AP duration is moderately sensitive to changes in all repolarization current conductances and in L-type Ca 2ϩ current (ICaL) and slow component of the delayed rectifier current (I Ks) inactivation kinetics. AP triangulation, however, is strongly dependent only on inward rectifier K ϩ current (IK1) and delayed rectifier current (IKr) conductances. Furthermore, AP rate dependence (i.e., AP duration rate adaptation and restitution properties) and intracellular Ca 2ϩ and Na ϩ levels are highly sensitive to both ICaL and Na ϩ /K ϩ pump current (I NaK) properties. This study provides quantitative insights into the sensitivity of preclinical biomarkers of arrhythmic risk to variations in ionic current properties in humans. The results show the importance of sensitivity analysis as a powerful method for the in-depth validation of mathematical models in cardiac electrophysiology. biological variability; arrhythmia; computer simulation VENTRICULAR ARRHYTHMIAS can be caused by disease, genetic mutations, and drug cardiotoxicity, which lead to changes in ionic current properties and often result in repolarization abnormalities. Research into arrhythmia mechanisms has identified a number of cellular electrophysiological properties as potential biomarkers of arrhythmic risk (31), the majority of which are related to action potential (AP) shape and duration (APD) and, importantly, their rate dependence. The prediction of an increase in arrhythmic risk caused by ionic changes is particularly important during the drug development process, as certain drugs can exhibit cardiotoxicity (i.e., unwanted side effects such as drug-induced alterations in cardiac ionic currents), which can put patients at risk of developing cardiac arrhythmias such as Torsades de Pointes (TdP). An optimal preclinical evaluation of drug cardiotoxicity is pivotal to reduce the huge costs of the drug development process since by the time a drug reaches the clinical trial stage, a large number of resources have been devoted to drug development. APD prolongation is considered the main preclinical biomarker of drug cardiotoxicity, because of its link to long QT syndrome. However, this has two important drawbacks: 1) the natural intra-and intersubject variability of APD, which makes it difficult to even define APD prolongation and 2) the variability in the proarrhythmic responses associated with ion current alterations that result in APD prolongation. In both cases variability arises not only through variability in one particular ion channel expression but also because of the complex electrophysiological interplay in which ion channel inhibition takes place. As recently described, this interplay varies due to both congenital and acquired mechanisms, including drug side effects as well as sex and age (44, 50, 51, 61) .
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The main goal of this study is to perform a systematic and quantitative investigation into how variability in ionic mechanisms modulates human ventricular cell electrophysiology and the main preclinical biomarkers of arrhythmic risk. The sensitivity of each biomarker to alterations in ionic currents properties was quantified using the most detailed human ventricular AP model to date, the ten Tusscher and Panfilov (2006) human ventricular AP model (TP06) (55), the predictive power of which has been demonstrated previously (37, 53) . Validation of simulation results was performed by a comparison to experimental data obtained in human ventricular cardiomyocytes available in the literature. The findings of our study provide new insights into the ionic basis of the main preclinical biomarkers of arrhythmic risk. In addition, this study identifies new experimental data required for a further understanding of human cellular electrophysiology and demonstrates the importance of sensitivity analysis as a powerful method for systematic and in-depth validation of AP models in cardiac electrophysiology.
METHODS

Action Potential Model
The electrophysiological activity of a human ventricular epicardial cell was simulated using the TP06 model (55) . Forward Euler integration with a time step of 0.02 ms was used to integrate the system of differential equations governing the cellular electrical behavior. To test the convergence, simulations with 0.001-ms time step displayed only minor differences (Ͻ5%) in the simulation results.
Stimulation Protocols
Four stimulation protocols were applied to the virtual human ventricular cardiomyocytes to characterize the main arrhythmic risk biomarkers proposed in the literature (see Fig. 1 (2, 24, 40, 59) . They were calculated from the simulations following the application of a train of 3,000 square transmembrane current pulses of 2-ms duration and twice the diastolic threshold at a cycle length (CL) of 1,000 ms. Stimulation currents were considered to be K ϩ currents as suggested in Hund et al. (27) . Steady-state APD at 90 and 50% repolarization (APD 90 and APD50, respectively) and AP triangulation (defined as the difference between APD 50 and APD90) were calculated (Fig. 1A, top) . Steady-state systolic and diastolic [Ca 2ϩ ]i at a CL of 1 (Fig. 1A, bottom) and 0.5 Hz were also determined.
APD restitution curves. Both theoretical and experimental studies have shown that steep restitution curves are related to an increased risk of occurrence of AP alternans and wavefront breakup, associated with the initiation and sustenance of lethal arrhythmias such as ventricular fibrillation (39, 60) . APD90 restitution curves were constructed using both S1S2 and dynamic restitution protocols. The S1S2 restitution protocol consisted of a train of 10 square current pulses (S1) at a CL of 1,000 ms, followed by an extra stimulus (S2) applied at coupling intervals (CIs) ranging from 5,000 to 50 ms (CI step ϭ 1 ms). The S1S2 restitution curve was obtained by plotting the APD90 elicited by S2 versus the diastolic interval (DI) for each CI (Fig. 1B,  top) . The dynamic restitution curve [used to characterize drug reverse rate dependence (31) ] was generated by plotting steady-state APD 90 versus steady-state DI for CLs ranging from 5,000 to 50 ms (Fig. 1B,  bottom) . The maximal slopes of S1S2 and dynamic restitution curves (slope max,S1S2 and slopemax,Dyn, respectively) were calculated.
APD rate adaptation to abrupt changes in CL. APD rate adaptation dynamics have been proposed as a clinical marker for arrhythmic risk (42) . As in previous clinical and experimental studies (17, 30) , APD 90 heart rate adaptation was characterized by recording APD90 during the following stimulation protocol: first, pacing at CL of 1,000 ms for 8 min, then at CL of 600 ms for 8 min, and finally at CL of 1,000 ms for 8 min (Fig. 1C) . APD 90 dynamics following each change in pacing rate were fitted to two exponential functions (41a), with time constants fast and slow, respectively. Because both time constants for both accelerating and decelerating rate transitions were similar, an APD90 adaptation when CL changes from CL of 1,000 to 600 ms was applied. ]i levels with varying stimulation rates were investigated using a frequency staircase protocol. Cardiomyocytes were paced at increasingly fast frequencies (0.25, 0.5, 1, 1.5, 2, 2.5, and 3 Hz) for 10 min, and systolic [Ca 2ϩ ]i and [Na ϩ ]i levels were recorded for each frequency and normalized to the respective levels at 0.25 Hz (Fig. 1D ).
Sensitivity Analysis
A sensitivity analysis was performed in the model to investigate how natural variability or drug-induced alterations in ionic current properties might modulate preclinical biomarkers of arrhythmic risk. The ionic current properties considered in the sensitivity study were the maximal conductances and time constants of the main transmembrane ionic currents involved in AP repolarization, namely, maximal conductance (G CaL) of the L-type Ca 2ϩ current (ICaL); activation gate time constant (d), as well as its fast and slow voltage-dependent inactivation gate time constants (f2 and f, respectively); maximal conductance (GKr) and activation and inactivation gate time constant (Xr1 and Xr2, respectively) of the rapid component of the delayed rectifier current (IKr); maximal current conductance (GKs); and activation time constant (Xs) of the slow component of the delayed rectifier current (IKs) and maximal conductance (GK1) of the inward rectifier K ϩ current (IK1), maximal activity of the Na ϩ /K ϩ pump (GNaK), and maximal activity of the Na ϩ /Ca 2ϩ exchanger (GNaCa). The sensitivity analysis was performed by varying one parameter at a time, by Ϫ30% and Ϫ15%, ϩ15% and ϩ30%, respectively. The magnitude of the changes imposed is in line with the natural variability reported experimentally in human ventricular tissue (15, 18, 28, 34, 52, 57, 58) . Simulations using the four protocols described in Simulation Protocols were conducted for each parameter data set, and the results were compared with experimental data in the literature. A total of 5,220 simulations were run.
Data Analysis
For each electrophysiological characteristic "c" and parameter "p," the indexes percentage of change (D c,p,a) and sensitivities (Sc,p) were calculated as follows:
with c p,a and ccontrol being the magnitude of the characteristic "c" when the parameter "p" is increased by "a" and under control conditions, respectively. Moreover, to identify the model parameters that had a stronger influence on each electrophysiological characteristic, a relative sensitivity r c,p was calculated as the ratio between each Sc,p and the maximum absolute value of Sc,p obtained for that particular "c."
RESULTS
Figures 2-7 illustrate the simulations results obtained using the protocols described in METHODS. Figure 2 depicts the time course of the simulated APs under control conditions and for 30% reduction of each parameter value. Figure 3 shows the relative sensitivities r c,p of all combinations of electrophysiological characteristics to parameter variations using a gray level scale. The effects of d , Xr1 , f2 , and Xr2 changes on electrophysiological characteristics were negligible and thus are not shown. White indicates the strongest relative sensitivity among all parameters, whereas black means that the parameter and characteristic are completely independent. For each row, the maximum absolute sensitivity S c,p exerted in a particular characteristic "c" among all parameters is also shown as a percent value. Figures 4 -6 
Steady-State AP Properties
Action potential duration. Simulations show that APD 90 is particularly sensitive to the inactivation kinetics properties of I Ks and I CaL (especially, Xs and f ) and the maximum conductances of all currents involved in repolarization and, in particular, G CaL , G Ks , and G Kr (Fig. 2, and 1st row of Fig. 3 ). (11, 34) , whereas a decrease in G Kr and G Ks results in APD 90 prolongation (5, 21, 24, 29, 31) . Interestingly, Na ϩ /K ϩ pump current (I NaK ) block moderately reduces APD 90 , in agreement with the effect of strophanthidin on the APD shown in experimental recordings on guinea pig cardiac myocytes (32) . The results from Levi et al. (32) show that a strophanthidin application results in an initial brief lengthening of APD because of a reduced outward current, followed by a sustained APD shortening caused by [Na ϩ ] i accumulation and the subsequent increase in the reverse mode of the Na ϩ /Ca 2ϩ exchange current (I NaCa ), which contributes to cell repolarization (14) . These effects are reproduced in our simulations.
Action potential triangulation. Figure 3 , second row, and Fig. 4B reveal the importance of G K1 and G Kr in AP triangulation. This is consistent with the experimental data showing that I K1 block with barium leads to a 25% increase in AP triangulation in dog (4) and that I Kr inhibition enhances AP triangulation in healthy (29) and diseased human myocytes (47), as well as in dog (31) and rabbit ventricular cells (24) . However, simulated AP triangulation is 31 ms in control, whereas experimentally reported values are larger and vary in the range between 44 (33) and 100 ms (34) (Fig. 4B) .
AP triangulation reflects relative changes between APD 90 and APD 50 , and it is roughly one order of magnitude smaller than APD 90 (under control conditions, they are 31 and 299.8 ms, respectively). Thus a particular intervention can result in significant percent changes in AP triangulation in the presence of only slight changes in APD 90 . Indeed, I K1 inhibition by 30% results in APD 90 prolongation by 1.9%, no change in APD 50 , and thus in a 16.1% increase in AP triangulation. In the case of G Kr reduction, both APD 90 and APD 50 are prolonged (Fig. 2B) , although APD 50 to a smaller extent than APD 90 , thus resulting in an increase of AP triangulation. By contrast, I Ks modulation of APD 90 and APD 50 are similar and, therefore, AP triangulation remains unchanged.
Steady-State [Ca 2ϩ ] i Dynamics
The simulation results show that G CaL and G NaCa are key in determining both systolic and diastolic [Ca 2ϩ ] i levels, with G CaL exerting the strongest influence at 1 Hz (179% sensitivity) and G NaCa at 0.5 Hz (269% sensitivity) (see Fig. 3 , rows 3-6, and Fig. 5 ). In addition, the I CaL inactivation gate time constant ( f ) and G NaK are also important determinants of [Ca 2ϩ ] i levels. These results are in agreement with experimental observations in human ventricular tissue (8, 22, 23, 48) . However, as illustrated in Fig. 5 Figure 3 , seventh row, highlights the importance of G NaK , G CaL , and to a lesser extent of I Ks activation kinetics and I CaL inactivation kinetics ( Xs and f ) in modulating slope max,S1S2 . Slope max,S1S2 is flattened by I NaK inhibition but becomes steeper with the reduction in the remaining parameters (Fig. 6A) . Figure 7 , A and B, depicts the simulated restitution curves for the control and also for the 30% reduction in G NaK , G CaL , Xs , and f for DIs Ͻ 600 and 160 ms, respectively. Changes in restitution slope induced by parameter variations are dependent on DI. I CaL inhibition increases the S1S2 restitution curve slope at DIs Ͻ 40 ms (and thus slope max,S1S2 ) but flattens the curve at longer DIs ( 7B), as shown experimentally using nisoldipine, an I CaL blocker, on isolated rabbit ventricular myocytes (56) . Similarly, faster I CaL inactivation and I Ks activation (i.e., decrease in f and Xs ) flatten the S1S2 restitution curve at all DIs, except for very short DIs (Fig. 7B) . Importantly, 30% variations in all parameters result in slope max,S1S2 still within the physiological range reported experimentally by Nash and coworkers (38) , as shown in Fig. 6A . 
Dynamic restitution curve.
As for slope max,S1S2 , simulated slope max,Dyn depends strongly on G NaK and, to a smaller extent, on G CaL , G Kr , and f (Fig. 3, 8th row, and Fig. 6B ). Our simulation results reveal that G CaL reduction from ϩ30 to Ϫ15% of the control value results in a slight flattening of the restitution curve (Fig. 6B) , whereas for 30% G CaL inhibition, the restitution curve flattens for DI Ͼ 60 ms and becomes steeper than in the control for DI Ͻ 60 ms (Fig. 7D) . The experimental results in human myocytes show that I CaL suppression in human myocytes significantly attenuates the rate-dependent abbreviation of APD for DI Ͼ 300 ms (34) , which is in agreement with our simulations results. However, experimental (43) and theoretical (16, 19) studies in dog and guinea pig show that I CaL inhibition results in a flattening of the restitution curve also at short DIs. This discrepancy with our simulation results in humans could be due to true animal species differences, heterogeneity in restitution properties (38) , or the fact that the dependency of dynamic restitution curve slope on I CaL properties is not well represented in the mathematical models.
Our simulation results also show that I Kr block increases the dynamic restitution slope, as experimentally recorded in human myocytes (29) . However, the experimental recordings by Jost et al. (29) , as well as previous experimental and simulation studies in dog and guinea pig (25, 26) , might suggest a more important contribution of I Kr to rate-related alterations of repolarization than the one observed in our simulations. This could be due to animal species differences (7) and also to model deficiencies in the representation of repolarization mechanisms.
APD adaptation to sudden sustained changes in stimulation rate. As in experimental and clinical studies (17, 30) , simulated APD rate adaptation follows two phases (rapid and slow) with time constants for control being fast ϭ 11 ms and slow ϭ 121 s, respectively, which are close to the experimental values reported by Franz and collaborators (dotted lines in Fig. 6 ) (17) .
As shown in Fig. 3 , eigth row, and in Fig. 6C , fast is strongly dependent on I CaL inactivation dynamics ( f ), consistent with experiments in human ventricular myocytes (34) , and also to a lesser extent on I Ks properties (both xs and G Ks ). In contrast, slow is only significantly influenced by G NaK (Fig.  3, 9th row) , with Na ϩ /K ϩ pump inhibition resulting in a prolonged slow (Fig. 6D) , consistent with experimental results in dog (6) .
Rate dependence of ionic concentrations. As reported in experimental studies in human and other animal species (1, 23, 40, 41) , simulated systolic [Ca 2ϩ ] i and [Na 2ϩ ] i levels increase with an increase in frequency, reaching a maximum at 2 and 2.5 Hz, respectively, for control model parameters (Fig. 1D) . However, the effect of the increasing stimulation frequency on systolic [Ca 2ϩ ] i is significantly larger in the simulations than the one reported experimentally (40, 41) (Fig. 6, E and F,  dotted lines) . Figure 3 , 10th row, shows that the maximum systolic [Ca 2ϩ ] i is highly sensitive to G NaK (with sensitivity ϭ 114%) and also, although to a lesser extent, to G CaL and f . [Na ϩ ] i frequency modulation, and thus the maximum systolic [Na ϩ ] i , is less sensitive to model parameters than maximum systolic Fig. 7 . S1S2 (A and B) and dynamic restitution curves (C and D) for control and for 30% reduction of model parameters for DI Ͻ 600 ms and DI Ͻ 160 ms, respectively.
[Ca 2ϩ ] i , with G CaL being the parameter exerting the maximum influence maximum systolic [Na ϩ ] (sensitivity ϭ 29%) followed by xs , G Ks , f , G NaK , and G Kr (Fig. 3, last row, and Fig.  6F ). The experimental results on the changes in [Na ϩ ] i with varying pacing rate are scarce. Prieske et al. (41) reported an increase in [Na ϩ ] i with an increasing pacing rate, consistent with our simulation results (see Fig. 1D, bottom) . However, the maximum increment they observed was 44%, which is significantly smaller than the one observed in our simulations (120%). In addition, they measured a concentration of 15.9 mmol/l at 0.25 Hz, larger than the simulated value of 5.6 mmol/l for control.
DISCUSSION
The TP06 Human Ventricular Model
In this article, the most detailed human ventricular model to date, the TP06 model, was used to systematically investigate the ionic basis of electrophysiological properties related to arrhythmic risk in human ventricular cardiomyocytes. As described in the original articles (54, 55) , three main types of data were used in the model development, namely, data on ionic currents, conductances, and kinetics; on steady-state AP and intracellular concentrations dynamics; and on frequency modulation of AP and intracellular concentrations. Many of the data were based on recordings in human ventricular tissue, but because of the scarcity of data from humans, the model parameter fitting was sometimes based on experimental data obtained from human atrium, cultured cells, and other animal species such as dog and guinea pig.
This study presents an analysis of the sensitivity of the model and, in particular, of the preclinical biomarkers of arrhythmic risk to changes in conductances and kinetics of the main ionic currents involved in repolarization. The applied changes in model parameters could represent natural intrasubject variability [as reported by Verkerk et al. (57) , for instance] and/or the effects of specific pharmacological interventions or channel mutations on electrophysiological properties. The simulation results were compared with the experimental data recorded in human tissue, when available, under control conditions and following pharmacological interventions mimicking the parameter changes introduced in our analysis. The results show that steady-state APD and APD restitution curve properties as well as APD adaptation dynamics are well reproduced by the model, both in terms of their control conditions and how they are modulated by varying ionic current properties. Other properties such as AP triangulation and [Ca 2ϩ ] i and [Na ϩ ] i levels show good qualitative agreement with the experimental results, but significant differences are observed quantitatively. Discrepancies between the experimental and simulated electrophysiological characteristics may lie on a parameter fitting not exclusively based on experimental human ventricular data because of the scarcity of data that characterize human ventricular electrophysiology. Thus the obtention of new experimental data will be very valuable for model improvement. This study demonstrates that sensitivity analysis, as performed in this study on the TP06 model, provides a good basis for the systematic validation and further improvement of AP models.
Sensitivity and Selectivity of Electrophysiological Biomarkers of Arrhythmic Risk
APD is the main preclinical biomarker used to assess the risk of TdP caused by drug-induced side effects or mutations. Our simulations show that APD is moderately sensitive (maximum sensitivity ϭ 42%) to changes in maximal conductances of all currents involved in repolarization and also I Ks and I CaL kinetics (Fig. 3, 1st row) . Thus the same APD value can be obtained for a variety of combinations of ionic current property values, without it providing any indication of arrhythmic risk stratification. The use of additional biomarkers is therefore needed to assess proarrhythmic risk preclinically based on cardiac cell electrophysiology.
The present study highlights important differences in the maximal sensitivity of electrophysiological properties associated with arrhythmic risk to changes in ionic current properties. The new insights provided could be key in improving the preclinical assessment of arrhythmic risk and also in identifying the potential mechanisms of arrhythmogenesis associated to particular subjects or interventions. For instance, the results of our study show that AP triangulation is mostly dependent on G K1 and, to a lesser extent, on G Kr , as experimentally observed (4, 24, 29, 31) . Thus increasing G K1 and G Kr reduces AP triangulation, thus predicting a decrease in the risk of TdP occurrence. Moreover, as shown in Fig. 3 , the steady-state [Ca 2ϩ ] i levels are highly dependent on both the conductance and kinetics of I CaL but also on G NaK and G NaCa . Additional biomarkers such as APD rate adaptation dynamics and restitution properties as well as [Ca 2ϩ ] i and [Na ϩ ] i levels are also highly sensitive to I CaL and I NaK properties. This highlights the importance of the two currents in cell homeostasis and arrhythmia mechanisms related to early afterdepolarizations and alternans.
Our results also show that the APD restitution curves become steeper for the enhanced activity of the Na ϩ /K ϩ pump, as well as for slow I CaL inactivation kinetics and I Ks activation kinetics (i.e., large f and Xs values), and thus the proarrhythmic potential of those interventions could be associated with an increased risk of alternans development, which is considered potentially proarrhythmic. However, other parameters, such as G CaL , increase the slope of the restitution curves at small CIs while flattening the curve at higher CIs.
The results of the present study also highlight the need for new experimental data to further our understanding of the ionic basis of ventricular electrophysiology in humans. An experimental validation is required for the pivotal role of the Na 
Limitations of the Study
In this study, a systematic analysis on the role of ionic current properties in modulating preclinical arrhythmic risk biomarkers has been performed using the most detailed human ventricular model to date. Simulations using the model yield electrophysiological properties that are, in most cases, in good agreement with experimental data obtained using human ventricular myocytes. However, some quantitative differences are observed, often related to [Ca 2ϩ ] i levels, highlighting the need for further improvements in the model development, which would also benefit from additional experimental data. Because of the scarcity of experimental results in undiseased human myocytes, data from diseased human tissue and other animal species were also used to develop the original TP06 model and to evaluate the simulation results in this study. Thus discrepancies between simulation and experimental results might be due to true animal species differences or to the fact that the model is, in some aspects, not optimally configured to represent undiseased human ventricular electrophysiological behavior.
In addition, our simulations do not account for transient changes in K ϩ concentration of the clefts surrounding the cells following an abrupt change in the stimulus. Although APD and its rate dependence in tissue might be modulated by the effect of stimulation rate on extracellular K ϩ concentration dynamics, previous studies suggest that these effects are not expected to play a major role in mammalian ventricular muscle (7) .
Furthermore, in the present article, we aimed to analyze the effect of the main transmembrane currents of the TP06 ionic model involved in AP repolarization on the main cellular biomarkers of arrhythmic risk. We have focused on analyzing the role of the maximum conductance and kinetics of the main transmembrane ionic currents involved in repolarization in modulating electrophysiological properties associated with arrhythmic risk. Additional model parameters, such as steadystate values of the gates, may also influence the cellular electrophysiological characteristics. The influence of the fast Na ϩ current has not been commented in the manuscript because, as expected (7), its effect on the biomarkers studied in this study was negligible. This was confirmed by our simulations (results not shown). Indeed, it is well known that the primary role of the fast Na ϩ current is in the depolarization phase of the AP. However, as drug-induced effects on Na ϩ channels might exert a critical influence in arrhythmias (9, 10, 20, 35) , further research on the influence of the fast Na ϩ current properties in properties such as AP depolarization, the conduction velocity or safety factor of propagation (45, 49) would be very valuable. In addition, although the late Na ϩ current might be important in TdP generation, its role has not been studied in this article since it is not included in the TP06 model. Furthermore, a complete study of drug-receptor interactions for each current and their rate-dependent effects was beyond the scope of the present study. Finally, interesting conclusions would arise from the study of the ion basis of the main preclinical biomarkers of arrhythmic risk under pathological conditions such as ischemia or heart failure, when cardiac arrhythmias are likely to appear.
Conclusions
This study provides new insights into the ionic basis of the electrophysiological biomarkers used to assess arrhythmic risk preclinically. More specifically, the simulation results provide a systematic investigation into how changes in specific ionic current properties (which could be caused by natural variability, genetic mutations, or drug-induced alterations) can modulate APD, AP triangulation, restitution properties, APD rate adaptation as well as [Ca 2ϩ ] i and [Na ϩ ] i , and its rate dependence. A comparison of the simulation results to the experimental data demonstrates that the sensitivity analysis performed here is a powerful method for the systematic and in-depth validation of AP models. It also highlights the need for additional experimental data to further our understanding of human ventricular myocyte electrophysiology.
